|Daily Range||$0.00 - $0.00|
|52-Week Range||$0.00 - $0.00|
|Dividend (Yield)||$0.00 (0.0%)|
|Average Daily Volume||0|
|Current FY EPS||-$0.69|
This fund sports a solid track record.
Finding companies that have all the right stuff can produce winners.
It was a relatively lackluster week for stocks, but some managed to post some serious gains.
Amgen and Celgene pull the trigger. Don't drop the keg.
Cancer, hepatitis and personalized medicine are the focus of recently announced takeovers. More M&A transactions are likely.